CIBC Asset Management Inc Raises Stock Holdings in Humana Inc. $HUM

CIBC Asset Management Inc lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 69.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,501 shares of the insurance provider’s stock after acquiring an additional 11,679 shares during the period. CIBC Asset Management Inc’s holdings in Humana were worth $7,300,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HUM. Capital International Investors purchased a new stake in shares of Humana in the third quarter valued at about $707,670,000. Norges Bank purchased a new stake in shares of Humana in the fourth quarter valued at about $456,632,000. Massachusetts Financial Services Co. MA raised its holdings in shares of Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares during the last quarter. Neuberger Berman Group LLC raised its holdings in shares of Humana by 2,855.5% in the third quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock valued at $138,092,000 after buying an additional 512,816 shares during the last quarter. Finally, 8 Knots Management LLC raised its holdings in shares of Humana by 671.0% in the second quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock valued at $107,968,000 after buying an additional 384,345 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 0.0%

Shares of HUM stock opened at $349.85 on Friday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $351.88. The stock has a market cap of $42.00 billion, a P/E ratio of 37.42, a P/E/G ratio of 2.00 and a beta of 0.76. The business has a fifty day simple moving average of $248.43 and a 200-day simple moving average of $232.40. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the business earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts forecast that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.0%. Humana’s dividend payout ratio is currently 37.86%.

Analysts Set New Price Targets

HUM has been the subject of a number of research reports. Bank of America upped their target price on shares of Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a report on Thursday. Morgan Stanley upped their target price on shares of Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a report on Thursday. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Wells Fargo & Company lowered shares of Humana from a “cautious” rating to a “reduce” rating in a research note on Wednesday, May 20th. Finally, Cantor Fitzgerald began coverage on shares of Humana in a research note on Wednesday, May 20th. They set an “overweight” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $279.30.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.